Moody Aldrich Partners LLC Replimune Group, Inc. Transaction History

Moody Aldrich Partners LLC

  • $503 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 28, 2023
BUY
$15.65 - $24.1 $291,246 - $448,501
18,610 Added 21.1%
106,808 $2.48 Million
Q1 2023

Apr 27, 2023
SELL
$17.48 - $29.09 $56,617 - $94,222
-3,239 Reduced 3.54%
88,198 $1.56 Million
Q4 2022

Jan 23, 2023
BUY
$17.09 - $27.91 $1.56 Million - $2.55 Million
91,437 New
91,437 $0

Others Institutions Holding REPL

# of Institutions
149
Shares Held
68M
Call Options Held
52.3K
Put Options Held
80.3K
View Full List

About Replimune Group, Inc.

REPL Quotes by TradingView
  • Ticker REPL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,306,700
  • Market Cap $631M
  • Description
  • Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...
More about REPL
Track This Portfolio

Track Moody Aldrich Partners LLC Portfolio

Follow Moody Aldrich Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moody Aldrich Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email